Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The PLK4 inhibitor RP-1664 demonstrates potent efficacy in neuroblastoma preclinical models through a dual mechanism of sensitivity.

Nature communications·2026
Same author

The multifaceted role of B cells in traumatic spinal cord injury: Antibody-dependent and antibody-independent mechanisms.

Neurobiology of disease·2026
Same author

BCL-2 and MCL1 co-inhibition enhances glucocorticoid therapy in preclinical models of infant KMT2A-rearranged acute lymphoblastic leukaemia.

British journal of haematology·2026
Same author

Enhanced MIF/CD74 axis activity shapes B cell functioning following traumatic spinal cord injury.

Journal of neuroinflammation·2026
Same author

Cytomegalovirus Drives the Development of Cytotoxic CD4<sup>+</sup> T Cells in Patients With Multiple Sclerosis.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Autoantibody biomarkers and first-line therapy response in RA: findings from the CAP48 cohort.

RMD open·2026

Related Experiment Video

Updated: Jun 23, 2026

Simultaneous Detection of Different Antibody Classes in a Multiplexed Serological Test
05:25

Simultaneous Detection of Different Antibody Classes in a Multiplexed Serological Test

Published on: July 14, 2023

Multiplexing approaches for autoantibody profiling in multiple sclerosis.

Klaartje Somers1, Cindy Govarts, Piet Stinissen

  • 1Hasselt University, Biomedical Research Institute, and Transnationale Universiteit Limburg, School of Life Sciences, Agoralaan, Building C, 3590 Diepenbeek, Belgium.

Autoimmunity Reviews
|April 28, 2009
PubMed
Summary

B cell depletion therapy shows promise for multiple sclerosis (MS). Researchers are developing a panel of autoantibodies to identify MS patients with high accuracy, aiding diagnosis and understanding disease mechanisms.

More Related Videos

Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies
10:16

Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies

Published on: September 15, 2016

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

Related Experiment Videos

Last Updated: Jun 23, 2026

Simultaneous Detection of Different Antibody Classes in a Multiplexed Serological Test
05:25

Simultaneous Detection of Different Antibody Classes in a Multiplexed Serological Test

Published on: July 14, 2023

Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies
10:16

Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies

Published on: September 15, 2016

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

Area of Science:

  • Neuroimmunology
  • Immunopathology
  • Biomarker Discovery

Background:

  • B cell depletion therapy shows promise in multiple sclerosis (MS), renewing interest in B cells and autoantibodies.
  • Autoantibodies are valuable disease markers for MS, despite no single specificity discriminating patients from controls.
  • Complexity of MS and overlapping autoantibody profiles necessitate multiplex profiling for accurate MS-associated autoantibody identification.

Purpose of the Study:

  • To identify a panel of MS-associated autoantibodies with high sensitivity and specificity.
  • To develop diagnostic and prognostic markers for MS.
  • To gain insights into MS disease processes and potential therapeutic targets.

Main Methods:

  • Application of high-throughput autoantibody profiling techniques.
  • Analysis of autoantibody profiles in MS cerebrospinal fluid.
  • Utilizing multiplex autoantibody profiling approaches.

Main Results:

  • Identification of a novel panel of 8 antigenic targets associated with MS.
  • Achieved 45% sensitivity and 86% specificity for MS detection using the identified panel.
  • Demonstrated the potential of multiplex autoantibody profiling for generating an MS-specific autoantibody fingerprint.

Conclusions:

  • MS-specific autoantibody specificities are crucial for developing diagnostic and prognostic markers.
  • This research provides a foundation for understanding MS pathogenesis and identifying novel therapeutic strategies.
  • Multiplex autoantibody profiling offers a promising avenue for advancing MS diagnostics and research.